-
It's time to increase chlamydia screening in your clinic. Results of a new study show that, despite current screening recommendations, more than 2 million people are infected with chlamydia in the United States.
-
The next patient in your exam room is a 35-year-old mother of three. When you talk with her about her risks for cancer, she tells you they are low, because no one in her family has had the disease. What is your next step?
-
Help women discuss HPV, cervical cancer, and Pap tests with health care providers, with a new brochure, "Ask How You Can Prevent Cervical Cancer."
-
Whether it's new onset or established disease, the PCP has an arsenal of diagnostic tests available. The array of tests, however, can be quite daunting in identifying the right test to order, especially in light of sensitivity and specificity, not to mention cost. This issue provides the PCP with a comprehensive survey of the diagnostic tests available, a guide to selection, an estimate of cost, and limitations of each test.
-
Treatment of systolic hypertension in older patients with systolic blood pressure of at least 160 mm Hg is supported by strong evidence. The evidence to support treatment of patients to the level of 140 mm Hg or those with baseline SBP of 140 to 159 mm Hg is less strong; thus, these treatment decisions should be more sensitive to patient preferences and tolerance of therapy.
-
Use of ß-blockers is associated with reduced risk of
fracture. The magnitude of reduction is similar to that seen with use of thiazides.
-
Toenail Chromium in Men With Diabetes and Cardiovascular Disease; Combination of Fenofibrate and Rosiglitazone and HDL Cholesterol; Outcomes for Patients with Diet-Controlled Diabetes
-
The FDA has approved a combination of 2 antiretrovirals, abacavir and lamivudine for the treatment of HIV-1 infections.
-
A calcium score < 100 eliminates the need for MPS, but patients with a negative MPS often have coronary calcium. These findings imply a potential role for applying CAC screening after MPS among patients manifesting normal MPS.
-
A retrospective study of 24,112 patients with coronary heart disease showed increased 30-day mortality in patients who received one or more blood transfusions for anemia compared to comparable patients not transfused.
